Oncology drugmaker says soaring platinum prices, higher import duties and lengthy import approvals have made production financially unviable, worsening shortages of key chemotherapy medicines
Oncology drugmaker says soaring platinum prices, higher import duties and lengthy import approvals have made production financially unviable, worsening shortages of key chemotherapy medicines
<iframe src="https://hindustansphere.com/embed/cluster/5b9661f9ca89b48cbd18ae74f0c9407981296f53" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Drug companies seek NPPA price revision for cancer drugs amid shortage"></iframe>
